ABS CGSO common mistakes
ABS CGSO · Understand the traps and how to avoid them.
When a patient presents with a known primary tumor and new symptoms, the candidate attributes all new findings to the established cancer or to treatment toxicity without considering a second primary or an unrelated diagnosis.
Anchoring on the known malignancy feels efficient and matches the 'cancer patient' framing of the vignette; candidates stop generating a differential once one serious diagnosis is on the list.
What to do instead
For every new symptom, explicitly list at least one non-cancer explanation and one second-primary explanation before attributing it to the known disease; state which features (timing, distribution, tempo) make metastasis more or less likely.
The candidate treats an unusual or rare tumor presentation as impossible because it does not fit the common demographic (e.g., dismissing a colorectal or lung cancer in a young, non-smoking patient), and picks the 'typical' age-appropriate diagnosis instead.
Pattern-recognition heuristics built from base rates override the specific red-flag details given in the stem; candidates weight epidemiology more heavily than the described clinical picture.
What to do instead
When red-flag features are present (weight loss, bleeding, persistent change in bowel habit, non-resolving symptoms), commit to investigating the serious diagnosis regardless of demographics, and name the test that would exclude it.
The candidate orders or interprets staging investigations in the wrong sequence, or interprets a single imaging result as definitive staging without integrating pathologic confirmation and the limitations of that modality.
Staging is memorized as a list of tests rather than a decision pathway; candidates forget that management hinges on whether the result would change treatment.
What to do instead
Before selecting a test, state what management decision it informs; if the answer would not change the plan, the test is not indicated. Pair each imaging claim with its known false-positive/false-negative caveats.
In multidisciplinary questions, the candidate selects a single-modality answer when the scenario clearly requires combined-modality sequencing, or picks the modality without specifying the correct order relative to surgery.
Candidates study each treatment modality in isolation and default to the most familiar or most aggressive option rather than reasoning about neoadjuvant versus adjuvant intent.
What to do instead
For each MDT vignette, explicitly state the intent (curative vs palliative), then the sequence (e.g., neoadjuvant therapy before resection for locally advanced disease), and justify why the alternative sequence is inferior in that scenario.
The candidate recommends surgery or aggressive local therapy for a patient whose performance status, comorbidity, or goals make such treatment inappropriate, ignoring frailty and patient preference.
Exam stems emphasize tumor stage, and candidates equate stage with treatment intensity, forgetting that fitness and goals of care are equally determinative.
What to do instead
Always assess performance status and comorbidity first; if either is poor, weigh palliative or less invasive options and state the trade-off between survival benefit and treatment burden explicitly.
The candidate treats a palliative scenario as if it were curative, or fails to recognize when the goal has shifted to symptom control, continuing toxic systemic therapy in a patient with clearly incurable, refractory disease.
Candidates conflate 'more treatment' with 'better care' and are uncomfortable selecting comfort-focused answers on a cancer exam.
What to do instead
Identify the goal of care at the start of every vignette; when the disease is incurable and performance status is declining, choose symptom-directed management and name the specific symptom being addressed.
The candidate overlooks rehabilitation needs entirely, focusing only on oncologic treatment and never addressing functional deficits, lymphedema, fatigue, or return-to-work issues.
Rehabilitation is perceived as a downstream, non-exam-relevant concern; candidates do not habitually screen for functional impairment in the vignette.
What to do instead
Screen every cancer patient for functional status, pain, fatigue, and lymphedema risk; when a deficit is described, name the specific rehab intervention (e.g., lymphedema therapy, physical therapy, cognitive rehab) and its timing relative to treatment.
The candidate ignores the psychosocial and vocational dimensions of survivorship, missing depression, anxiety, sexual dysfunction, or fertility and return-to-work concerns that are explicitly signaled in the stem.
Candidates focus on tumor biology and physical findings and treat psychosocial cues as background rather than as the question being asked.
What to do instead
Treat any mention of mood, relationships, work, or fertility as a primary issue; name the screening tool or referral (e.g., distress screening, fertility preservation counseling before gonadotoxic therapy) as the answer.
The candidate recommends a screening test without matching it to the patient's age, risk category, and evidence base, or applies a screening test to a symptomatic patient who requires diagnostic workup instead.
Screening guidelines are memorized as fixed rules rather than as risk-stratified recommendations; candidates confuse screening with diagnosis.
What to do instead
For each screening question, state the patient's risk category (average vs high risk), the recommended test and interval, and confirm the patient is asymptomatic; if symptomatic, the answer is diagnostic evaluation, not screening.
The candidate fails to apply primary prevention and risk-reduction measures (vaccination, tobacco cessation, chemoprevention, genetic counseling for high-risk families) when the vignette presents an opportunity to prevent cancer rather than detect it.
Candidates default to 'find the cancer' thinking and do not habitually consider prevention, genetic risk assessment, or modifiable risk factors as the correct answer.
What to do instead
When a stem describes risk factors or family history, first ask whether a prevention or risk-assessment action (HPV or HBV vaccination, cessation counseling, BRCA or Lynch syndrome referral) is the indicated next step before any screening or diagnostic test.